Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

Overview of attention for article published in Arthritis Research & Therapy, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

Il trattamento con abatacept migliora molti outcome riferiti dai pazienti (PRO) affetti da artrite psoriasica (PsA).

medwireNews : Treatment with abatacept is associated with improvements in patient-reported outcomes (PROs) among individuals…

19-12-2018 | Rheumatology | News | Article medwireNews: Treatment with abatacept is associated with improvements in patient-repor…

To explore the effect of abatacept treatment on patient -reported outcomes (PROs) in psoriatic arthritis (PsA).

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.